These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22487763)

  • 21. Bilateral asynchronous renal cell carcinoma: treatment approach.
    Kessler OJ; Livne PM; Servadio C
    Isr J Med Sci; 1993 Nov; 29(11):721-5. PubMed ID: 8270406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current practice patterns in the surgical management of renal cancer in the United States.
    Sivarajan G; Huang WC
    Urol Clin North Am; 2012 May; 39(2):149-60, v. PubMed ID: 22487758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Open partial nephrectomy: standard of minimal invasive surgery].
    Dezael JC; Briffaux R; Fromont G; Pirès C; Doré B; Irani J
    Prog Urol; 2011 Dec; 21(13):917-24. PubMed ID: 22118356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laparoscopic versus open radical nephrectomy in T1-T2 renal carcinoma: personal 5-year experience about the oncologic outcome.
    Siani LM; Ferranti F; Benedetti M; De Carlo A; Quintiliani A
    Minerva Chir; 2011 Aug; 66(4):317-21. PubMed ID: 21873966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ablative techniques for the management of kidney cancer.
    Hafron J; Kaouk JH
    Nat Clin Pract Urol; 2007 May; 4(5):261-9. PubMed ID: 17483811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous laparoendoscopic single-site radical nephrectomy for native kidney and open nonischemic partial nephrectomy to treat concomitant renal cell carcinomas in native and transplant kidneys and to preserve allograft function.
    Sankari BR; Chueh SC
    Urology; 2012 Jan; 79(1):139-44. PubMed ID: 22055688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanding the indications of partial nephrectomy.
    Rogers CG
    Eur Urol; 2011 Jun; 59(6):938-9. PubMed ID: 21440982
    [No Abstract]   [Full Text] [Related]  

  • 30. Predicting cancer-control outcomes in patients with renal cell carcinoma.
    Karakiewicz PI; Hutterer GC
    Curr Opin Urol; 2007 Sep; 17(5):295-302. PubMed ID: 17762620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
    Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ
    Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expanding the indications for laparoscopic radical nephrectomy.
    Mattar K; Finelli A
    Curr Opin Urol; 2007 Mar; 17(2):88-92. PubMed ID: 17285016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous radiofrequency ablation: minimally invasive therapy for renal tumors.
    Ahrar K; Wallace MJ; Matin SF
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1735-44. PubMed ID: 17181487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expanding role of partial nephrectomy: a critical analysis of indications, results, and complications.
    Touijer K; Jacqmin D; Kavoussi LR; Montorsi F; Patard JJ; Rogers CG; Russo P; Uzzo RG; Van Poppel H
    Eur Urol; 2010 Feb; 57(2):214-22. PubMed ID: 19853988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Approach to the small renal mass: to treat or not to treat.
    Kim SP; Thompson RH
    Urol Clin North Am; 2012 May; 39(2):171-9, vi. PubMed ID: 22487760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephron sparing surgery for renal tumors: indications, techniques and outcomes.
    Uzzo RG; Novick AC
    J Urol; 2001 Jul; 166(1):6-18. PubMed ID: 11435813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor enucleation vs sharp excision in minimally invasive partial nephrectomy: technical benefit without impact on functional or oncologic outcomes.
    Mukkamala A; Allam CL; Ellison JS; Hafez KS; Miller DC; Montgomery JS; Weizer AZ; Wolf JS
    Urology; 2014 Jun; 83(6):1294-9. PubMed ID: 24713137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimally invasive surgery for renal cell carcinoma.
    Ghoneim IA; Fergany AF
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):989-97. PubMed ID: 19589037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.
    Thompson RH; Boorjian SA; Lohse CM; Leibovich BC; Kwon ED; Cheville JC; Blute ML
    J Urol; 2008 Feb; 179(2):468-71; discussion 472-3. PubMed ID: 18076931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephron-sparing surgery.
    Lane BR; Novick AC
    BJU Int; 2007 May; 99(5 Pt B):1245-50. PubMed ID: 17441918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.